Key facts
- AGelity Biomechanics’s last known valuation is $15.8M (Dec 2025).
- It has raised $6.8M; the latest was Seed Round ($6.8M) in Dec 2025.
- Notable investors include Plug and Play Tech Center, Robin Hood Ventures, Tony Chen.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for AGelity Biomechanics
- ·The full record, as it builds
Funding rounds
No funding rounds for AGelity Biomechanics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AGelity Biomechanics
Developer of non-degradable implants designed to offer early-stage treatments for healthy adults with injury-induced osteoarthritis. The company addresses the lack of reliable osteoarthritis treatments using implant technology, with an initial focus on treating knee OA, enabling patients with osteoarthritis to get treated early.
- Sector
- Healthcare
- HQ
- Montville, NJ, United States
- Founded
- 2014
- Employees
- 9
- Website
- agelitybiomechanics.com/
- Ownership
- Privately Held (backing)
AGelity Biomechanics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AGelity Biomechanics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AGelity Biomechanics in its N-PORT filings yet. We sweep new filings monthly.